High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: Up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial

Blood

Volumn 92, Issue 9, 1998, Pages 3131-3136

  Fermand, Jean Paul ^a   Ravaud, Philippe ^b   Chevret, Sylvie ^b   Divine, Marine ^b   Leblond, Véronique ^b   Belanger, Coralie ^b   Macro, Margaret ^b   Pertuiset, Edouard ^b   Dreyfus, François ^b   Mariette, Xavier ^b   Boccacio, Catherine ^b   Brouet, Jean Claude ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW RESCUE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0032211193     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3131.421k30_3131_3136     Document Type: Article

References (27)

1. Alexanian R, Dimopoulos M: Drug therapy: The treatment of multiple myeloma. N Engl J Med 330:484, 1994
2. Blade J, San Miguel JF, Fontanillas M, Alcala A, Maldonado J, Garcia-Conde J, Conde E, Conzalez-Brito G, Moro MJ, Escudero ML, Trujillo J, Pascual A, Rozman C, Estapoe J, Montserrat E: Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/auto-transplantation and who were conventionally treated. J Clin Oncol 14:2167, 1996
3. Selby PJ, McElwain TJ, Nandi AC, Perren TJ, Powles RL, Tillyet CR, Osborne RJ, Slevin ML, Malpas JS: Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol 66:55, 1987
4. Bensinger WI, Demirer T, Buckner CD, Appelbaum FR, Storb R, Lilleby K, Weiden P, Bluming AZ, Fefer A: Syngeneic marrow transplantation in patients with multiple myeloma. Bone Marrow Transplant 18:527, 1996
5. Gahrton G, Tura S, Ljungman P, Belanger C, Brandt L, Cavo M, Facon T, Granena A, Gore M. Gratwohl A, Löwenberg B, Nikoskelainen J, Reiffers JJ, Samson D, Verdonck L, Volin L, for the European Group for Bone Marrow Transplantation: Allogeneic bone marrow transplantation in multiple myeloma. N Engl J Med 325:1267, 1991
6. Barlogie B, Hall R, Dicke K, Alexanian R: High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 67:1298, 1986
7. Gore ME, Selby PJ, Virer C, Clark P, Melbrum M, Millar B, Bell J, Maitland J, Milan S, Judson I, Zuiable A, McElwain T: Intensive treatment of multiple myeloma and criteria for complete remission. Lancet 2:879, 1989
8. Fermand JP, Levy Y, Gerota, Benbunan M, Cosset JM, Castaigne S, Seligmann M, Brouet JC: Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood 73:20, 1989
9. Bensinger WI, Bichner CD. Gahrton G: Allogeneic stem cell transplantation for multiple myeloma. Hematol Oncol Clin North Am 11:147, 1997
10. Jagannath S, Barlogie B, Dicke K, Alexanian A, Zagars G, Cheson B, Lemaistre FC, Smallwood L, Pruitt K, Dixon DO: Autologous bone marrow transplantation in multiple myeloma: Identification of prognostic factors. Blood 76:1860, 1990
11. Attal M, Huguet F, Schlaifer D, Payen C, Laroche M, Fournie B, Mazieres B, Pris J, Laurent G: Intensive combined therapy for previously untreated aggressive myeloma. Blood 79:1130, 1992
12. Lokhorst HM, Meuwissen OJ, Verdonck LF, Dekker AW: High-risk multiple myeloma treated with high-dose melphalan. J Clin Oncol 10:47, 1992
13. Fermand JP, Chevret S, Ravaud P, Divine M, Leblond V, Dreyfus F, Mariette X, Brouet JC: High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: Results of a phase II trial involving 63 patients. Blood 82:2005, 1993
14. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JB, Rossi JF Casassus P, Maisonnneuve H, Facon T, Ifrah N, Payen C, Bataille R, for the Intergroupe Français du Myélome: A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91, 1996
15. Fermand JP, Chevret S, Levy Y, Miclea JM, Tsapis A, Gerota J, Benbunan M, Brouet JC: The role of autologous blood stem cells in support of high-dose therapy for multiple myeloma. Hematol Oncol Clin North Am 6:451, 1992
16. Cole BF, Gelber RD, Anderson KM: Parametric approaches to quality-adjusted survival analysis. Biometrics 50:621, 1994
17. Whitehead J: The Design and Analysis of Sequential Clinical Trials (ed 2). Chichester, UK, Ellis Horwood, 1992
18. Vesole, DH, Tricot G, Jagannath S, Desikan KR, Siegel D, Bracy D, Miller L, Cheson B, Crowley J, Barlogie B: Autotransplants in multiple myeloma: What have we learned ? Blood 88:838, 1996
19. Kyle RA: Why better prognostic factors for multiple myeloma are needed? Blood 83:1713, 1994
20. Gelber RD, Cole BF, Goldhirsch A, Rose C, Fisher B, Osborne CK, Boccardo F, Gray R, Gordon N, Bengtsson NO, Sevelda P: Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta-analysis of quality-adjusted survival. Lancet 347:1066, 1996
21. Lenderking WR, Gelber RD, Cole BF, Goldhirsch A, Volberding PA, Testa MA: Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. N Engl J Med 330:738 1994
22. To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 89:2233, 1997
23. Govindarajan R, Jagannath S, Flick JT, Vesole DH, Sawyer J, Barlogie B, Tricot G: Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma. Br J Haematol 95:349, 1996
24. Barlogie B, Jagannath S, Vesole DH, Naucke S, Cheson B, Mattox S, Bracy D, Salmon S, Jacobson J, Crowley J, Tricot G: Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 89:789, 1997
25. Björkstrand B, Ljungman P, Bird JM, Samson D, Gahrton G: Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma. Bone Marrow Transplant 15:367, 1995
26. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
27. Johnson RJ, Owen RG, Smith GM, Child JA, Galvin M, Newton LJ, Rawstron A, Major K, Woodhead V, Robinson F, Jack A, Morgan GJ: Peripheral blood stem cell transplantation in myeloma using CD34 selected cells. Bone Marrow Transplant 17:723, 1996